株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

オピオイドの世界市場:将来予測

Global Opioids Market Research Report Forecast to 2023

発行 Market Research Future 商品コード 882299
出版日 ページ情報 英文 159 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.67円で換算しております。
Back to Top
オピオイドの世界市場:将来予測 Global Opioids Market Research Report Forecast to 2023
出版日: 2019年06月30日 ページ情報: 英文 159 Pages
概要

当レポートでは、世界のオピオイド市場について分析し、製品の概要や市場の基本構造、主な市場促進・抑制要因、全体的な市場動向の見通し (過去3年間・今後5年間分)、製品別・用途別・エンドユーザー別・地域別の詳細動向、市場シェア構造、主要企業のプロファイル・業績・戦略などを調査しております。

第1章 序論

第2章 分析概略

第3章 分析手法

第4章 市場のダイナミクス

  • イントロダクション
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第5章 市場要因の分析

  • ポーターのファイブフォース分析
  • バリューチェーン分析
    • 研究開発 (R&D)
    • 製造
    • 流通
    • マーケティング・販売
    • アフターサービス/モニタリング
  • 需要と供給:ギャップ分析
  • 価格動向の分析

第6章 世界のオピオイド市場:製品別

  • 概要
  • 持続放出性/長時間作用型オピオイド
  • 即時放出型/短時間作用型オピオイド

第7章 世界のオピオイド市場:用途別

  • 概要
  • 疼痛緩和 (痛み止め)
  • 麻酔
  • 咳止め
  • 下痢止め
  • 依存症治療

第8章 世界のオピオイド市場:エンドユーザー別

  • 概要
  • 病院・クリニック
  • 薬局
  • 教育・研究機関

第9章 世界のオピオイド市場:地域別

  • 概要
  • 南北アメリカ
    • 北米諸国 (米国、カナダ)
    • ラテンアメリカ諸国
  • 欧州
    • 西欧諸国 (ドイツ、英国、フランス、スペイン、イタリアなど)
    • 東欧諸国
  • アジア太平洋地域
    • 中国、日本、インド、オーストラリア、韓国など
  • 中東・アフリカ

第10章 競争環境

  • 企業別市場シェアの分析
    • 概要

第11章 企業プロファイル

  • Sanofi SA
    • 企業概要
    • 主な財務指標
    • 主要製品/サービス
    • 近年の主な動向
    • SWOT分析
    • 主要戦略
  • Pfizer Inc
  • Boehringer Ingelheim GmbH
  • Teva Pharmaceutical Industries Ltd
  • Allergan Inc.
  • Purdue Pharma L.P.
  • West-Ward Pharmaceuticals Corporation
  • Sun Pharmaceutical Industries Ltd
  • Egalet Corporation
  • Janssen Global Services, LLC
  • Vertice Pharma LLC
  • Mallinckrodt

第12章 付録

図表

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL OPIOIDS MARKET FOR PAIN RELIEF, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL OPIOIDS MARKET FOR ANESTHESIA, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL OPIOIDS MARKET FOR COUGH SUPPRESSION, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL OPIOIDS MARKET FOR DIARRHOEA SUPPRESSION, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL OPIOIDS MARKET FOR DEADDICTION, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 16 GLOBAL OPIOIDS MARKET FOR HOSPITALS & CLINICS, BY REGION, (USD MILLION)
  • TABLE 17 GLOBAL OPIOIDS MARKET FOR PHARMACIES, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 18 GLOBAL OPIOIDS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 19 GLOBAL OPIOIDS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 20 AMERICAS: OPIOIDS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 21 AMERICAS: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 22 AMERICAS: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 23 AMERICAS: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 24 AMERICAS: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 25 AMERICAS: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 26 AMERICAS: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 27 NORTH AMERICA: OPIOIDS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 28 NORTH AMERICA: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 29 NORTH AMERICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 30 NORTH AMERICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 31 NORTH AMERICA: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 32 NORTH AMERICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 33 NORTH AMERICA: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 34 US: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 35 US: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 36 US: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 37 US: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 38 US: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 39 US: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 40 CANADA: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 41 CANADA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 42 CANADA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 43 CANADA: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 44 CANADA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 45 CANADA: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 46 LATIN AMERICA: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 47 LATIN AMERICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 48 LATIN AMERICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 49 LATIN AMERICA: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 50 LATIN AMERICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 51 LATIN AMERICA: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 52 EUROPE: OPIOIDS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 53 EUROPE: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 54 EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 55 EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 56 EUROPE: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 57 EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 58 EUROPE: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 59 WESTERN EUROPE: OPIOIDS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 60 WESTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 61 WESTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 62 WESTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 63 WESTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 64 WESTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 65 WESTERN EUROPE: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 66 GERMANY: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 67 GERMANY: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 68 GERMANY: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 69 GERMANY: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 70 GERMANY: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 71 GERMANY: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 72 UK: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 73 UK: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 74 UK: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 75 UK: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 76 UK: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 77 UK: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 78 FRANCE: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 79 FRANCE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 80 FRANCE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 81 FRANCE: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 82 FRANCE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 83 FRANCE: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 84 SPAIN: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 85 SPAIN: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 86 SPAIN: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 87 SPAIN: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 88 SPAIN: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 89 SPAIN: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 90 ITALY: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 91 ITALY: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 92 ITALY: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 93 ITALY: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 94 ITALY: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 95 ITALY: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 96 REST OF WESTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 97 REST OF WESTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 98 REST OF WESTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 99 REST OF WESTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 100 REST OF WESTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 101 REST OF WESTERN EUROPE: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 102 EASTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 103 EASTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 104 EASTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 105 EASTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 106 EASTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 107 EASTERN EUROPE: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 108 ASIA-PACIFIC: OPIOIDS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 109 ASIA-PACIFIC: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 110 ASIA-PACIFIC: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 111 ASIA-PACIFIC: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 112 ASIA-PACIFIC: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 113 ASIA-PACIFIC: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 114 ASIA-PACIFIC: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 115 CHINA: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 116 CHINA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 117 CHINA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 118 CHINA: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 119 CHINA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 120 CHINA: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 121 JAPAN: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 122 JAPAN: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 123 JAPAN: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 124 JAPAN: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 125 JAPAN: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 126 JAPAN: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 127 INDIA: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 128 INDIA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 129 INDIA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 130 INDIA: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 131 INDIA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 132 INDIA: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 133 AUSTRALIA: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 134 AUSTRALIA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 135 AUSTRALIA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 136 AUSTRALIA: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 137 AUSTRALIA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 138 AUSTRALIA: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 139 SOUTH KOREA: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 140 SOUTH KOREA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 141 SOUTH KOREA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 142 SOUTH KOREA: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 143 SOUTH KOREA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 144 SOUTH KOREA: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 145 REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 146 REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 147 REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 148 REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 149 REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 150 REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 151 MIDDLE EAST & AFRICA: OPIOIDS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 153 MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 154 MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA : OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 156 MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 157 MIDDLE EAST & AFRICA : OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 158 MIDDLE EAST: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 159 MIDDLE EAST: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 160 MIDDLE EAST: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 161 MIDDLE EAST: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 162 MIDDLE EAST: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 163 MIDDLE EAST: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 164 AFRICA: OPIOIDS MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 165 AFRICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 166 AFRICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 167 AFRICA: OPIOIDS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 168 AFRICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 169 AFRICA: OPIOIDS MARKET, BY END USER, 2015-2023 (USD MILLION)

List of Figures

  • FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES
  • FIGURE 2 MARKET DYNAMICS: GLOBAL OPIOIDS MARKET
  • FIGURE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL OPIOIDS MARKET
  • FIGURE 4 SUPPLY CHAIN: OPIOIDS MARKET
  • FIGURE 5 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2017 & 2023 (USD MILLION)
  • FIGURE 6 GLOBAL OPIOIDS MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
  • FIGURE 7 GLOBAL OPIOIDS MARKET, BY END USER, 2017 & 2023 (USD MILLION)
  • FIGURE 8 GLOBAL OPIOIDS MARKET, BY REGION, 2017 & 2023 (USD MILLION)
  • FIGURE 9 AMERICAS: OPIOIDS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 10 NORTH AMERICA: OPIOIDS MARKET SHARE, BY COUNTRY, 2017 (%)
  • FIGURE 11 EUROPE: OPIOIDS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 12 WESTERN EUROPE: OPIOIDS MARKET SHARE, BY COUNTRY, 2017 (%)
  • FIGURE 13 ASIA-PACIFIC: OPIOIDS MARKET SHARE, BY COUNTRY, 2017 (%)
  • FIGURE 14 MIDDLE EAST & AFRICA: OPIOIDS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 15 GLOBAL OPIOIDS MARKET SHARE ANALYSIS, 2017 (%)
目次

Introduction

Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties. They are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses.

The main purpose of opioids is to treat conditions inducing chronic pain such as cancers, arthritis, lower back pain, and fibromyalgia. The market for opioids is increasing due to the growing geriatric population, coupled with an increasing focus on palliative care and technological advancements in opioids. However, drug misuse and addiction are likely to hamper the market growth over the forecast period.

The global opioids market is growing at a rapid pace. The global opioids market is expected to reach USD 29,535.80 million by 2023 from USD 19,554.49 million in 2017 and is expected to register a CAGR of 7.12% during the forecast period of 2018 to 2023.

In 2017, the market was led by the Americas with a 77.49% share, followed by Europe, and Asia-Pacific with shares of 10.69% and 8.1%, respectively.

The market has been segmented based on product, application, and end-user.

The global opioids market on the basis of product has been segmented into immediate-release/short-acting opioid and extended-release/long-acting opioid. Immediate-release/short-acting opioid is further sub-segmented into codeine, oxycodone, hydrocodone, fentanyl, morphine, propoxyphene, and others. Extended-release/long-acting opioid is further sub-segmented into oxycodone, hydrocodone, methadone, fentanyl, morphine, oxymorphone, and others. The extended-release opioid segment accounted for the larger market share of 65.21% in 2017, with a market value of USD 12,750.91 million; it is expected to register a CAGR of 6.96% during the forecast period.

The global opioids market on the basis of application has been segmented into pain relief and anesthesia. Pain relief is further sub-segmented into cancer pain, postoperative pain management, low-back pain, orthopedic pain, neuropathic pain, and fibromyalgia. Anesthesia is further sub-segmented into cough suppression, diarrhea suppression, and de-addiction. The pain relief segment accounted for the largest market share of 38.09% in 2017, with a market value of USD 7,448.51 million; it is expected to register a CAGR of 6.28% during the forecast period.

The global opioids market on the basis of end user has been segmented into hospitals and clinics, pharmacies, academic research institutes, and others. The hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period.

Key Players

Sanofi SA, Pfizer Inc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, Allergan Inc., Purdue Pharma L.P., West-Ward Pharmaceuticals Corporation, Sun Pharmaceutical Industries Ltd, Egalet Corporation, Janssen Global Services, LLC, Vertice Pharma LLC, and Mallinckrodt

Study Objectives

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global opioids market

  • To provide insights into factors influencing and affecting the market growth
  • To provide historical and forecast revenue of market segments and sub-segments with respect to countries
  • To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
  • To provide economic factors that influence the global opioids market
  • To provide a detailed analysis of the value chain and supply chain of the global opioids market

Target Audience

  • Research and Development (R&D) Companies
  • Pharmaceutical Companies
  • Government Research Institutes
  • Academic Institutes and Universities
  • Research Laboratories
  • Hospitals and Clinics

Key Findings

  • The global opioids market is expected to reach USD 29,535.80 million by 2023 at a CAGR of 7.12% from 2018 to 2023
  • The Americas accounted for the largest market share of 77.49% in 2017, with a market value of USD 15,151.87 million; the market is expected to register a CAGR of 6.72% during the forecast period. Europe was the second-largest market in 2017, valued at USD 2,091.00 million; the market is projected to exhibit a CAGR of 7.34%. However, the market in Asia-Pacific is expected to register the highest CAGR of 10.34%.
  • On the basis of end user, the hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period. The pharmacies segment was the second-largest market in 2017, valued at USD 4,368.80 million; it is projected to exhibit a CAGR of 7.31%. However, the academic research institutes segment is expected to register the highest CAGR of 7.53%.
  • On the basis of application, the anesthesia segment was the second-largest market in 2017, valued at USD 4,082.84 million; the market is projected to register the highest CAGR of 7.94%.

Regional Analysis

  • Americas
    • North America
  • US
  • Canada
    • Latin America
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Republic of Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Middle East
    • Africa

Table of Contents

1 Report Prologue

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Research Objective
  • 2.4 Assumptions & Limitations
    • 2.4.1 Assumptions
    • 2.4.2 Limitations
    • 2.4.3 Market Structure

3 Research Methodology

  • 3.1 Primary Research Methodology
  • 3.2 Secondary Research Methodology
  • 3.3 Market Size Estimation
  • 3.4 Forecast Model

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia
    • 4.2.2 Favorable reimbursement policies for palliative care in developed regions
    • 4.2.3 Substantial rise in road accidents, trauma, and surgical procedures
  • 4.3 Restraints
    • 4.3.1 Rising addiction and death cases due to overdose of opioid
  • 4.4 Opportunities
    • 4.4.1 Reconsideration of prescribing opioid analgesics due to rising awareness about opioids misuse, abuse, and overdose has prompted many stakeholders

5 Market Factor Analysis

  • 5.1 Porter's Five Forces Model
    • 5.1.1 Bargaining Power of Suppliers
    • 5.1.2 Bargaining Power of Buyers
    • 5.1.3 Threat of New Entrants
    • 5.1.4 Threat of Substitutes
    • 5.1.5 Intensity of Rivalry
  • 5.2 Value Chain Analysis
    • 5.2.1 Research &Development
    • 5.2.2 Manufacturing
    • 5.2.3 Distribution
    • 5.2.4 Marketing & Sales
    • 5.2.5 Post-Sales Monitoring
  • 5.3 Demand & Supply: Gap Analysis
  • 5.4 Pricing Analysis

6 Global Opioids Market, by Product

  • 6.1 Overview
  • 6.2 Extended-Release/Long-Acting Opioid
  • 6.3 Immediate-Release/Short-Acting Opioid

7 Global Opioids Market, by Application

  • 7.1 Overview
  • 7.2 Pain Relief
  • 7.3 Anesthesia
  • 7.4 Cough Suppression
  • 7.5 Diarrhoea Suppression
  • 7.6 Deaddiction

8 Global Opioids Market, by End User

  • 8.1 Overview
  • 8.2 Hospitals & Clinics
  • 8.3 Pharmacies
  • 8.4 Academic Research Institutes

9 Global Opioids Market, by Region

  • 9.1 Overview
  • 9.2 Americas
    • 9.2.1 North America
    • 9.2.2 US
    • 9.2.3 Canada
    • 9.2.4 Latin America
  • 9.3 Europe
    • 9.3.1 Western Europe
    • 9.3.2 Germany
    • 9.3.3 UK
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Italy
    • 9.3.7 Rest of Western Europe
    • 9.3.8 Eastern Europe
  • 9.4 Asia-Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia-Pacific
  • 9.5 Middle East & Africa
    • 9.5.1 Middle East
    • 9.5.2 Africa

10 Competitive Landscape

  • 10.1 Company Market Share Analysis
    • 10.1.1 Overview

11 Company Profile

  • 11.1 Sanofi SA
    • 11.1.1 Company Overview
    • 11.1.2 Financial Overview
    • 11.1.3 Products/Services Offered
    • 11.1.4 Key Developments
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Strategy
  • 11.2 Pfizer Inc
    • 11.2.1 Company Overview
    • 11.2.2 Financial Overview
    • 11.2.3 Products/Services Offered
    • 11.2.4 Key Developments
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Strategy
  • 11.3 Boehringer Ingelheim GmbH
    • 11.3.1 Company Overview
    • 11.3.2 Financial Overview
    • 11.3.3 Products/Services Offered
    • 11.3.4 Key Developments
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Strategy
  • 11.4 Teva Pharmaceutical Industries Ltd
    • 11.4.1 Company Overview
    • 11.4.2 Financial Overview
    • 11.4.3 Products/Services Offered
    • 11.4.4 Key Developments
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Strategy
  • 11.5 Allergan Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financial Overview
    • 11.5.3 Products/Services Offered
    • 11.5.4 SWOT Analysis
    • 11.5.5 Key Developments
    • 11.5.6 Key strategy
  • 11.6 Purdue Pharma L.P.
    • 11.6.1 Company Overview
    • 11.6.2 Financial Overview
    • 11.6.3 Products/Services Offered
    • 11.6.4 Key Developments
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Strategy
  • 11.7 West-Ward Pharmaceuticals Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Financial Overview
    • 11.7.3 Products/Services Offered
    • 11.7.4 Key Developments
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Strategy
  • 11.8 Sun Pharmaceutical Industries Ltd
    • 11.8.1 Company Overview
    • 11.8.2 Financial Overview
    • 11.8.3 Products/Services Offered
    • 11.8.4 Key Developments
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Strategy
  • 11.9 Egalet Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Financial Overview
    • 11.9.3 Products/Services Offered
    • 11.9.4 Key Developments
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Strategy
  • 11.1 Janssen Global Services, LLC
    • 11.10.1 Company Overview
    • 11.10.2 Financial Overview
    • 11.10.3 Products/Services Offered
    • 11.10.4 Key Developments
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Strategy
  • 11.11 Vertice Pharma LLC
    • 11.11.1 Company Overview
    • 11.11.2 Financial Overview
    • 11.11.3 Products/Services Offered
    • 11.11.4 Key Developments
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Strategy
  • 11.12 Mallinckrodt
    • 11.12.1 Company Overview
    • 11.12.2 Financial Overview
    • 11.12.3 Products/Services Offered
    • 11.12.4 Key Developments
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Strategy

12 Appendix

Back to Top